Citigroup Maintains Buy on Pulmonx, Raises Price Target to $16
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Joanne Wuensch maintains a Buy rating on Pulmonx (NASDAQ:LUNG) and raises the price target from $14 to $16.
July 11, 2023 | 2:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Pulmonx and raises the price target from $14 to $16.
The news of Citigroup maintaining a Buy rating and raising the price target for Pulmonx is likely to instill confidence in investors and could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100